• 1
    Parkin DM, Bray F, Ferlay J et al. Global cancer statistics, 2002. CA Cancer J Clin 2005;55:74108.
  • 2
    Ferlay J, Bray F, Pisani P et al. GLOBOCAN 2002: Cancer incidence, mortality and prevalence worldwide. IARC Cancer Base No. 5, version 2.0, Lyon: IARC Press, 2004. Available at: [accessed Nov 25, 2006].
  • 3
    Bosch FX, Manos MM, Munoz N et al. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group. J Natl Cancer Inst 1995;87:796802.
  • 4
    Walboomers JMM, Jacobs MV, Manos MM et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999;189:129.
  • 5
    Munoz N, Bosch FX, De Sanjos S et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003;384:51827.
  • 6
    Castellsague X, Diaz M, De Sanjose S et al. Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors: implications for screening and prevention. J Natl Cancer Inst 2006;98:30315.
  • 7
    Franco EL. Chapter 13: Primary screening of cervical cancer with human papillomavirus tests. J Natl Cancer Inst Monogr 2003;31:8996.
  • 8
    Harper DM, Franco EL, Wheeler C et al. Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial. Lancet 2004;364:175765.
  • 9
    Schiffman M, Castle PE. The promise of global cervical-cancer prevention. N Engl J Med 2005;353:21014.
  • 10
    Munoz N, Bosch FX, Castellsague X et al. Against which human papillomavirus types shall we vaccinate and screen? The international perspective. Int J Cancer 2004;111:27885.
  • 11
    Clifford GM, Smith JS, Plummer M et al. Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis. Br J Cancer 2003;88:6373.
  • 12
    Clifford GM, Smith JS, Aguado T et al. Comparison of HPV type distribution in high-grade cervical lesions and cervical cancer: a meta-analysis. Br J Cancer 2003;89:1015.
  • 13
    Clifford GM, Rana RK, Franceschi S et al. Human papillomavirus genotype distribution in low-grade cervical lesions: comparison by geographic region and with cervical cancer. Cancer Epidemiol Biomarkers Prev 2005;14:115764.
  • 14
    Huang S, Afonina I, Miller BA et al. Human papillomavirus types 52 and 58 are prevalent in cervical cancers from Chinese women. Int J Cancer 1997;70:40811.
  • 15
    Lin QQ, Yu SZ, Qu W et al. Human papillomavirus types 52 and 58. Int J Cancer 1998;75:4845.
  • 16
    Lo KW, Cheung TH, Chung TK et al. Clinical and prognostic significance of human papillomavirus in a Chinese population of cervical cancers. Gynecol Obstet Invest 2001;51:2027.
  • 17
    Lo KW, Wong YF, Chan MK et al. Prevalence of human papillomavirus in cervical cancer: a multicenter study in China. Int J Cancer 2002;100:32731.
  • 18
    Peng HQ, Liu SL, Mann V et al. Human papillomavirus types 16 and 33, herpes simplex virus type 2 and other risk factors for cervical cancer in Sichuan Province, China. Int J Cancer 1991;47:7116.
  • 19
    Stephen AL, Thompson CH, Tattersall MH et al. Analysis of mutations in the URR and E6/E7 oncogenes of HPV 16 cervical cancer isolates from central China. Int J Cancer 2000;86:695701.
  • 20
    Yu MY, Tong J, Chan PKS et al. Hypermethylation of the tumor suppressor gene RASSFIA and frequent concomitant loss of heterozygosity at 3p21 in cervical cancers. Int J Cancer 2003;105:2049.
  • 21
    Gao YE, Zhang J, Wu J et al. Detection and genotyping of human papillomavirus DNA in cervical cancer tissues with fluorescence polarization. Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai) 2003;35:102934.
  • 22
    Liu J, Rose B, Huang X et al. Comparative analysis of characteristics of women with cervical cancer in high- versus low-incidence regions. Gynecol Oncol 2004;94:80310.
  • 23
    Wu YP, Chen YL, Li LY et al. Associations of high-risk HPV types and viral load with cervical cancer in China. J Clin Virol 2006;35:2649.
  • 24
    Chen SL, Han CP, Tsao YP et al. Identification and typing of human papillomavirus in cervical cancers in Taiwan. Cancer 1993;72:193945.
  • 25
    Chen TM, Chen CA, Wu CC et al. The genotypes and prognostic significance of human papillomaviruses in cervical cancer. Int J Cancer 1994;57:1814.
  • 26
    Lai HC, Sun CA, Yu MH et al. Favorable clinical outcome of cervical cancers infected with human papilloma virus type 58 and related types. Int J Cancer 1999;84:5537.
  • 27
    Yang YC, Shen J, Tate JE et al. Cervical cancer in young women in Taiwan: prognosis is independent of papillomavirus or tumor cell type. Gynecol Oncol 1997;64:5963.
  • 28
    Lin H, Moh JS, Ou YC et al. A simple method for the detection and genotyping of high-risk human papillomavirus using seminested polymerase chain reaction and reverse hybridization. Gynecol Oncol 2005;96:8491.
  • 29
    Yang YY, Koh LW, Tsai JH et al. Correlation of viral factors with cervical cancer in Taiwan. J Microbiol Immunol Infect 2004;37:2827.
  • 30
    Huang LW, Chao SL, Chen PH et al. Multiple HPV genotypes in cervical carcinomas: improved DNA detection and typing in archival tissues. J Clin Virol 2004;29:2716.
  • 31
    Ho CM, Chien TY, Huang SH et al. Integrated human papillomavirus types 52 and 58 are infrequently found in cervical cancer, and high viral loads predict risk of cervical cancer. Gynecol Oncol 2006;102:5460.
  • 32
    Huang HJ, Huang SL, Lin CY et al. Human papillomavirus genotyping by a polymerase chain reaction-based genechip method in cervical carcinoma treated with neoadjuvant chemotherapy plus radical surgery. Int J Gynecol Cancer 2004;14:63949.
  • 33
    Chan MK, Lau KM, Tsui Y et al. Human papillomavirus infection in Hong Kong Chinese women with normal and abnormal cervix—detection by polymerase chain reaction method on cervical scrapes. Gynecol Oncol 1996;60:21723.
  • 34
    Chan PKS, Li WH, Chan MYM et al. High prevalence of human papillomavirus type 58 in Chinese women with cervical cancer and precancerous lesions. J Med Virol 1999;59:2328.
  • 35
    Wu CH, Lee MF, Chang MC et al. Detection of human papillomavirus types in cervical lesions of patients from Taiwan by the polymerase chain reaction. Sex Transm Dis 1994;21:30914.
  • 36
    Lai HC, Sytwu HK, Sun CA et al. Single nucleotide polymorphism at FAS promoter is associated with cervical carcinogenesis. Int J Cancer 2003;103:2215.
  • 37
    Dai M, Bao YP, Li N et al. Human papillomavirus infection in Shanxi Province, People’s Republic of China: a population-based study. Br J Cancer 2006;95:96101.
  • 38
    Li LK, Dai M, Clifford GM et al. Human papillomavirus infection in Shenyang City, People’s Republic of China: a population-based study. Br J Cancer 2006;95:15937.
  • 39
    Asato T, Maehama T, Nagai Y et al. A large case-control study of cervical cancer risk associated with human papillomavirus infection in Japan, by nucleotide sequencing–based genotyping. J Infect Dis 2004;189:182932.
  • 40
    Fujinaga Y, Shimada M, Okazawa K et al. Simultaneous detection and typing of genital human papillomavirus DNA using the polymerase chain reaction. J Gen Virol 1991;72:103944.
  • 41
    Harima Y, Sawada S, Nagata K. Human papilloma virus (HPV) DNA associated with prognosis of cervical cancer after radiotherapy. Int J Radiat Oncol Biol Phys 2002;52:134551.
  • 42
    Ishikawa H, Mitsuhashi N, Sakurai H et al. The effects of p53 status and human papillomavirus infection on the clinical outcome of patients with stage IIIB cervical carcinoma treated with radiation therapy alone. Cancer 2001;91:809.
  • 43
    Kashiwabara K, Nakajima T. Detection of human papillomavirus DNA in invasive cervical cancers by the polymerase chain reaction and its clinical significance. Acta Pathol Jpn 1992;42:87683.
  • 44
    Maki H, Saito S, Ibaraki T et al. Use of universal and type-specific primers in the polymerase chain reaction for the detection and typing of genital human papillomaviruses. Jpn J Cancer Res 1991;82:4119.
  • 45
    Nakagawa S, Yoshikawa H, Onda T et al. Type of human papillomavirus is related to clinical features of cervical carcinoma. Cancer 1996;78:193541.
  • 46
    Nakagawa H, Sugano K, Fujii T et al. Frequent detection of human papilloma viruses in cervical dysplasia by PCR single-strand DNA-conformational polymorphism analysis. Anticancer Res 2002;22:165560.
  • 47
    Saito J, Hoshiai H, Noda K. Type of human papillomavirus and expression of p53 in elderly women with cervical cancer. Gynecol Obstet Invest 2000;49:1903.
  • 48
    Sasagawa T, Basha W, Yamazaki H et al. High-risk and multiple human papillomavirus infections associated with cervical abnormalities in Japanese women. Cancer Epidemiol Biomarkers Prev 2001;10:4552.
  • 49
    Tsuda H, Hashiguchi Y, Nishimura S et al. Relationship between HPV typing and abnormality of G1 cell cycle regulators in cervical neoplasm. Gynecol Oncol 2003;91:47685.
  • 50
    Yamakawa Y, Forslund O, Teshima H et al. Human papillomavirus DNA in adenocarcinoma and adenosquamous carcinoma of the uterine cervix detected by polymerase chain reaction (PCR). Gynecol Oncol 1994;53:1905.
  • 51
    Kanao H, Enomoto T, Ueda Y et al. Correlation between p14 (ARF)/p16(INK4A) expression and HPV infection in uterine cervical cancer. Cancer Lett 2004;213:317.
  • 52
    Nobeyama H, Sumi T, Misugi F et al. Association of HPV infection with prognosis after neoadjuvant chemotherapy in advanced uterine cervical cancer. Int J Mol Med 2004;14:1015.
  • 53
    Nawa A, Nishiyama Y, Kobayashi T et al. Association of human leukocyte antigen-B1*03 with cervical cancer in Japanese women aged 35 years and younger. Cancer 1995;75:51821.
  • 54
    Hwang TS, Jeong JK, Park M et al. Detection and typing of HPV genotypes in various cervical lesions by HPV oligonucleotide microarray. Gynecol Oncol 2003;90:516.
  • 55
    Kim KH, Kim YS. Role of human papillomavirus and p53 tumor suppressor gene in cervical carcinogenesis. Yonsei Med J 1995;36:41225.
  • 56
    Hwang T. Detection and typing of human papillomavirus DNA by PCR using consensus primers in various cervical lesions of Korean women. J Korean Med Sci 1999;14:5939.
  • 57
    Park TC, Kim CJ, Koh YM et al. Human papillomavirus genotyping by the DNA chip in the cervical neoplasia. DNA Cell Biol 2004;23:11925.
  • 58
    An HJ, Kim KR, Kim IS et al. Prevalence of human papillomavirus DNA in various histological subtypes of cervical adenocarcinoma: a population-based study. Mod Pathol 2005;18:52834.
  • 59
    An HJ, Cho NH, Lee SY et al. Correlation of cervical carcinoma and precancerous lesions with human papillomavirus (HPV) genotypes detected with the HPV DNA chip microarray method. Cancer 2003;97:167280.
  • 60
    Cho NH, An HJ, Jeong JK et al. Genotyping of 22 human papillomavirus types by DNA chip in Korean women: comparison with cytologic diagnosis. Am J Obstet Gynecol 2003;188:5662.
  • 61
    Yoshida T, Fukuda T, Sano T et al. Usefulness of liquid-based cytology specimens for the immunocytochemical study of p16 expression and human papillomavirus testing. Cancer 2004;102:1008.
  • 62
    Nagai Y, Maehama T, Asato T et al. Persistence of human papillomavirus infection after therapeutic conization for CIN 3: is it an alarm for disease recurrence? Gynecol Oncol 2000;79:2949.
  • 63
    Yoshikawa H, Kawana T, Kitagawa K et al. Detection and typing of multiple genital human papillomaviruses by DNA amplification with consensus primers. Jpn J Cancer Res 1991;82:52431.
  • 64
    Yoshikawa H, Nagata C, Noda K et al. Human papillomavirus infection and other risk factors for cervical intraepithelial neoplasia in Japan. Br J Cancer 1999;80:6214.
  • 65
    Ichimura H, Yamaguchi S, Kojima A et al. Eradication and reinfection of human papillomavirus after photodynamic therapy for cervical intraepithelial neoplasia. Int J Clin Oncol 2003;8:3225.
  • 66
    Niwa K, Tagami K, Lian Z et al. Topical vidarabine or 5-fluorouracil treatment against persistent HPV in genital (pre)cancerous lesions. Oncol Rep 2003;10:143741.
  • 67
    Hwang HS, Park M, Lee SY et al. Distribution and prevalence of human papillomavirus genotypes in routine pap smear of 2,470 Korean women determined by DNA chip. Cancer Epidemiol Biomarkers Prev 2004;13:21536.
  • 68
    Kim CJ, Jeong JK, Park M et al. HPV oligonucleotide microarray-based detection of HPV genotypes in cervical neoplastic lesions. Gynecol Oncol 2003;89:2107.
  • 69
    Oh LY, Shin JK, Han J et al. Significance of high-risk human papillomavirus detection by polymerase chain reaction in primary cervical cancer screening. Cytopathology 2001;12:7583.
  • 70
    Maehama T. Epidemiological study in Okinawa, Japan, of human papillomavirus infection of the uterine cervix. Infect Dis Obstet Gynecol 2005;13:7780.
  • 71
    Shin HR, Lee DH, Herrero R et al. Prevalence of human papillomavirus infection in women in Busan, South Korea. Cancer 2003;103:41321.
  • 72
    Sajio J, Fukuda T, Hoshiai H et al. High-risk types of human papillomavirus associated with the progression of cervical dysplasia to carcinoma. J Obstet Gynaecol Res 1999;25:2816.
  • 73
    Bhatla N, Dar L, Patro A et al. Human papillomavirus type distribution in cervical cancer in Delhi, India. Int J Gynecol Pathol 2006;25:398402.
  • 74
    Franceschi S, Rajkumar T, Vaccarella S et al. Human papillomavirus and risk factors for cervical cancer in Chennai, India: a case-control study. Int J Cancer 2003;107:12733.
  • 75
    Munirajan AK, Kannan K, Bhuvarahamurthy V et al. The status of human papillomavirus and tumor suppressor genes p53 and p16 in carcinomas of uterine cervix from India. Gynecol Oncol 1998;69:2059.
  • 76
    Sowjanya AP, Jain M, Poli UR et al. Prevalence and distribution of high-risk human papilloma virus(HPV) types in invasive squamous cell carcinoma of the cervix and in normal women in Andhra Pradesh, India. BMC Infectious Diseases 2005;5:116.
  • 77
    Hamkar R, Azad TM, Mahmoodi M et al. Prevalence of human papillomavirus in Mazandaran Province. Islamic Republic of Iran. East Mediterr Health J 2002;8:80511.
  • 78
    Mortazavi S, Zali M, Raoufi M et al. The prevalence of human papillomavirus in cervical cancer in Iran. Asian Pac J Cancer Prev 2002;3:6972.
  • 79
    Franceschi S, Snijders PJF, Arslan A et al. Papillomavirus infection in rural women in Southern India. Br J Cancer 2005;92:6016.
  • 80
    Bhattarakosol P, Lertworapreecha M. Survey of human papillomavirus infection in cervical intraepithelial neoplasia in Thai women. J Med Assoc Thai 2002;85(Suppl. 1):S3605.
  • 81
    Chichareon S, Herrero R, Munoz N et al. Risk factors for cervical cancer in Thailand: a case–control study. J Natl Cancer Inst 1998;90:507.
  • 82
    Siritantikorn S, Laiwejpithaya S, Siripanyaphinyo U et al. Detection and typing of human papillomavirus DNAs in normal cervix, intraepithelial neoplasia and cervical cancer in Bangkok. Southeast Asian J Trop Med Public Health 1997;28:70710.
  • 83
    Settheetham-Ishida W, Kanjanavirojkul N, Kularbkaew C et al. Human papillomavirus genotypes and the p53 codon 72 polymorphism in cervical cancer of Northeastern Thailand. Microbiol Immunol 2005;49:41721.
  • 84
    Sriamporn S, Snijders PJF, Pientong C et al. Human papillomavirus and cervical cancer from a prospective study in Khon Kaen, Northeast Thailand. Int J Gynecol Cancer 2006;16:2669.
  • 85
    Yadav M, Nurhayati ZA, Padmanathan A et al. Polymerase chain reaction detection and restriction enzyme typing of human papillomavirus in cervical carcinoma. Med J Malaysia 1995;50:6471.
  • 86
    Ngelangel C, Munoz N, Bosch FX et al. Causes of cervical cancer in the Philippines: a case–control study. J Natl Cancer Inst 1998;90:439.
  • 87
    Schellekens MC, Dijkman A, Aziz MF et al. Prevalence of single and multiple HPV types in cervical carcinomas in Jakarta, Indonesia. Am J Pathol 2000;157:105562.
  • 88
    Ekalaksananan T, Pientong C, Kotimanusvanij D et al. The relationship of human papillomavirus (HPV) detection to pap smear classification of cervical-scraped cells in asymptomatic women in northeast Thailand. J Obstet Gynaecol Res 2001;27:11724.
  • 89
    Lertworapreecha M, Bhattarakosol P, Niruthisard S. Detection and typing of human papillomavirus in cervical intraepithelial neoplasia grade III in Thai women. Southeast Asian J Trop Med Public Health 1998;29:50711.
  • 90
    Limpaiboon T, Pooart J, Bhattarakosol P. et al. p53 status and human papillomavirus infection in Thai women with cervical carcinoma. Southeast Asian J Trop Med Public Health 2000;31:6671.
  • 91
    Bosch FX. Preface. Vaccine 2006;24(Suppl. 3):vvi.
  • 92
    Clifford GM, Gallus S, Herrero R et al. Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis. Lancet 2005;366:9918.
  • 93
    Clifford GM, Franceschi S, Diaz M et al. Chapter 3: HPV type-distribution in women with and without cervical neoplastic diseases. Vaccine 2006;24(Suppl. 3):S2634.
  • 94
    Woodman CB, Collins S, Rollason TP et al. Human papillomavirus type 18 and rapidly progressing cervical intraepithelial neoplasia. Lancet 2003;361:403.
  • 95
    Schwartz SM, Daling JR, Shera KA et al. Human papillomavirus and prognosis of invasive cervical cancer: a population-based study. J Clin Oncol 2001;19:190615.